According to Dermapharm's latest financial reports the company's total liabilities are $1.70 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2022-12-31 | $0.94 B | -8.23% |
2021-12-31 | $1.02 B | -7.18% |
2020-12-31 | $1.10 B | 29.93% |
2019-12-31 | $0.85 B | 66.02% |
2018-12-31 | $0.51 B | 25.11% |
2017-12-31 | $0.41 B | 55.28% |
2016-12-31 | $0.26 B | -4.23% |
2015-12-31 | $0.27 B | -23.54% |
2014-12-31 | $0.36 B | -15.37% |
2013-12-31 | $0.42 B |